Indoco Remedies has recorded a growth of 13.5 per cent in the revenues at Rs 1645.3 million during the second quarter of FY 2012-13 as compared to Rs 1449.8 million over the same quarter last year. The un-audited results for the second quarter of the financial year 2012-13 were announced by the Board of Directors of Indoco Remedies at their meeting held in Mumbai.
Commenting on the performance, Suresh G Kare, Executive Chairman said, “Our domestic business is doing well with growth rates better than that of industry average for the current as well as previous quarter. On the international business front, the projects signed with alliance partners are getting commercialised. As envisaged, the company is set to take a big leap by registering higher growth consistently.”
The net revenues stood at Rs.1645.3 million, EBIDTA at Rs 260.4 million, and Profit after Tax was reported at Rs 120.8 million.
EP News Bureau